Clinical Edge Journal Scan

Bronchoscopy remains a safe choice for most patients with malignant hematologic disorders


 

Key clinical point : Bronchoscopy was safe for most patients with malignant hematologic disorders with careful monitoring and use of sedatives, particularly midazolam.

Major finding : A total of 12 out of 272 patients (3.8%) experienced prolonged oxygen desaturation; 7 of these recovered and 5 died from lung lesion deterioration. However, midazolam reduced the risk of prolonged oxygen desaturation in the study population.

Study details : The data come from a review of 316 bronchoscopies in 282 adults with malignant hematologic disorders and pulmonary infiltrates who were treated at a single center.

Disclosures: Lead author Dr. Uruga disclosed grant support from Okinaka Memorial Institute for Medical Research.

Citation: Uruga H et al. BMC Pulm Med. 2020 Sep 11. doi: 10.1186/s12890-020-01283-8.

Recommended Reading

ASH tackles COVID-19 with hematology-related FAQ, promotes new registries
Federal Practitioner
COVID-19 may be more lethal in MDS patients
Federal Practitioner
New form of programmed cell death has cancer treatment implications
Federal Practitioner
Genome study identifies potential treatment target for myelodysplastic syndrome patients
Federal Practitioner
Dialysis predicts increased risk of myelodysplastic syndrome
Federal Practitioner